William Rizzo
Clinical Genetics (M.D.) · Omaha, NENPI 1780635839
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Mirum Pharmaceuticals, Inc. at 38.0% of the total. 2025 is the largest year on record at $4,285, more than ten times the $379 reported in 2019.
Across 58 payments — averaging $174.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$4K
- Ultragenyx Pharmaceutical Inc.$3K
- Amgen$2K
- Biomarin Pharmaceutical Inc.$664
- Sanofi$275
- Amicus Therapeutics, Inc.$157
- plus $257 from 7 others
Across 60 payments — averaging $2664.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$85K
- Takeda Pharmaceuticals U.S.A., Inc.$64K
- Sanofi US Services Inc.$11K
What the payments were for
- Consulting fees$5,90058%
- Speaking & faculty fees$1,77518%
- Travel & lodging$8428%
- Food & beverage$1,54715%
- Education$561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 6 | $3,848 |
| Ultragenyx Pharmaceutical Inc. | 5 | $3,416 |
| Amgen | 5 | $1,504 |
| Biomarin Pharmaceutical Inc. | 15 | $664 |
| Sanofi | 6 | $275 |
| Amicus Therapeutics, Inc. | 8 | $157 |
| Shire North American Group Inc | 3 | $58 |
| Travere Therapeutics, Inc. | 5 | $48 |
| PTC Therapeutics, Inc. | 1 | $48 |
| Recordati_rare_diseases_inc. | 1 | $34 |
| UCB, Inc. | 1 | $32 |
| Intrabio Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Omaha
- Craig BakerOmaha$945
- Richard LutzOmaha$314
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.